A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease
Clinical trial NCT02923375 · COMPLETED
Trial details
- NCT number
- NCT02923375
- Sponsor
- Cynata Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-08-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.